Since PPAR-γ is a target for insulin-sensitizing agents, activation of PPAR-γ induced by telmisartan would be expected to improve insulin resistance and hyperglycemia in animals with high-fat diet-induced obesity. Here, INS is linked to Hyperglycemia.